We are live on ! Find out more
GDRX icon

GoodRx Holdings

192 hedge funds and large institutions have $5.14B invested in GoodRx Holdings in 2020 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 51 increasing their positions, 18 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 18

67% more first-time investments, than exits

New positions opened: 107 | Existing positions closed: 64

50% more funds holding in top 10

Funds holding in top 10: 69 (+3)

29% more funds holding

Funds holding: 149192 (+43)

15.89% less ownership

Funds ownership: 305.43%289.54% (-16%)

24% less capital invested

Capital invested by funds: $6.73B → $5.14B (-$1.59B)

54% less call options, than puts

Call options by funds: $34.7M | Put options by funds: $76M

Holders
192
Holders Change
+43
Holders Change %
+28.86%
% of All Funds
3.4%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
107
Increased
51
Reduced
18
Closed
64
Calls
$34.7M
Puts
$76M
Net Calls
-$41.4M
Net Calls Change
-$39M
Name Holding Trade Value Shares
Change
Change in
Stake
CWG
76
Cornerstone Wealth Group
North Carolina
$1.66M +$1.9M +41,255 New
WC
77
Wexford Capital
Florida
$1.64M +$1.87M +40,606 New
QT
78
Quantbot Technologies
New York
$1.61M +$1.84M +40,005 New
Simplex Trading
79
Simplex Trading
Illinois
$1.56M +$1.58M +34,303 +779%
DRS
80
Deane Retirement Strategies
Louisiana
$1.53M +$1.75M +37,993 New
Parallax Volatility Advisers
81
Parallax Volatility Advisers
California
$1.51M +$1.73M +37,550 New
Qube Research & Technologies (QRT)
82
Qube Research & Technologies (QRT)
United Kingdom
$1.46M +$1.66M +36,060 New
RPAM
83
Rhenman & Partners Asset Management
Sweden
$1.41M +$1.61M +35,000 New
MS
84
Madden Securities
Texas
$1.39M +$1.59M +34,555 New
LPL Financial
85
LPL Financial
California
$1.39M +$1.31M +28,450 +474%
Skandinaviska Enskilda Banken (SEB)
86
Skandinaviska Enskilda Banken (SEB)
Sweden
$1.38M +$1.57M +34,100 New
CG
87
Cutler Group
California
$1.37M +$900K +19,600 +136%
CCM
88
Cinctive Capital Management
New York
$1.34M -$2.73M -59,327 -64%
Bank of New York Mellon
89
Bank of New York Mellon
New York
$1.2M +$1.36M +29,630 New
KLCM
90
KG&L Capital Management
Louisiana
$1.06M +$1M +21,817 +494%
Envestnet Asset Management
91
Envestnet Asset Management
Illinois
$1.05M +$997K +21,706 +509%
AAS
92
Avantax Advisory Services
Texas
$1.01M +$1.14M +24,893 New
Commonwealth Equity Services
93
Commonwealth Equity Services
Massachusetts
$970K +$783K +17,052 +243%
Wolverine Trading
94
Wolverine Trading
Illinois
$950K +$1.03M +22,473 New
PAA
95
Peregrine Asset Advisers
Oregon
$930K +$1.06M +23,052 New
ACM
96
Atika Capital Management
New York
$879K -$1.3M -28,205 -56%
Koshinski Asset Management
97
Koshinski Asset Management
Illinois
$827K +$942K +20,512 New
PA
98
Parallel Advisors
California
$758K +$863K +18,794 New
Truist Financial
99
Truist Financial
North Carolina
$672K +$740K +16,103 New
WWM
100
Wolff Wiese Magana
California
$666K +$759K +16,510 New

GDRX Hedge Fund Activity: Q4 2020 in Review

192 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q4 2020, worth a combined $5.14B — down 24% from $6.73B a quarter earlier.

Buyers outnumbered sellers: 107 funds opened new GDRX positions and 64 closed out — a net gain of 43 holders — while 51 added to existing stakes and 18 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $104M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $125M sold.

  • 192 institutional investors held GoodRx Holdings (GDRX) as of Q4 2020, up from 149 in Q3 2020.
  • Funds reported $5.14B of GoodRx Holdings stock for Q4 2020, down 24% quarter-over-quarter.
  • 107 funds opened new GoodRx Holdings positions in Q4 2020 and 64 closed out, a net change of +43 holders.
  • The largest GoodRx Holdings buyer in Q4 2020 was Goldman Sachs, an estimated $104M added.
  • The largest GoodRx Holdings seller in Q4 2020 was T. Rowe Price Associates, an estimated $125M sold.

Based on aggregated 13F filings for Q4 2020.